Critically BOS needs to commercialise product and obtain a cashflow. All well and good in theory but execution is now required of the directors. This appears to be the conclusion also drawn by Prof Steinberg CEO.
The share structure is reasonably tight with the University and Restoration holding over 30%. The disaster for shareholders would be to give the technology away to some predator. I'm sure that this has exercised the minds of directors.
$5.00? That would give a market cap of $0.5M - BOS would need several key products to achieve that result but you are right, therapeutics would change the corporate dynamics. Cooling towers and hand wash, however, are a welcome start.
worth billions, page-5
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
